RxDoctor Payments Data

Christopher Park, DO

Family Medicine · Pontotoc, MSNPI 1710181078

Payments from drug & device makers

$2,607in general payments, 2019–2025

Across 172 payments — averaging $15.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$562
  • Amgen$328
  • AstraZeneca$204
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$191
  • Pfizer$156
  • Takeda Pharmaceuticals U.S.A., Inc.$137
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$2,607100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,607 in reported general payments places this provider in the 75th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$158,893
Medicare patients
250
Services billed
4,206

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide227$223,861
MounjaroTirzepatide136$165,688
Trelegy ElliptaFluticasone/Umeclidin/Vilanter108$92,460
VraylarCariprazine Hcl57$91,799
LinzessLinaclotide103$89,893
TrulicityDulaglutide50$75,367
FarxigaDapagliflozin Propanediol69$60,855
GenvoyaElviteg/Cob/Emtri/Tenof Alafen13$50,925
EliquisApixaban42$42,388
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl261$37,742
Tresiba Flextouch U-200Insulin Degludec26$35,960
JardianceEmpagliflozin49$35,441
XareltoRivaroxaban34$29,167
Breztri AerosphereBudesonide/Glycopyr/Formoterol41$26,207
TradjentaLinagliptin17$23,157

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$96$241,055186 claims
Novo NordiskOzempic$34$223,861227 claims
AbbVieVraylar, Linzess$562$181,692160 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$204$101,173164 claims
GSKTrelegy Ellipta, Anoro Ellipta$27$100,000121 claims
PfizerEliquis$156$42,38842 claims
Johnson & JohnsonXarelto$38$29,16734 claims
Orexo US, Inc.Zubsolv$54$19,99019 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$137$14,82631 claims
Indivior Inc.Suboxone$107$13,21929 claims
Astellas Pharma US IncMyrbetriq$23$10,25122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Pontotoc

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →